Literature DB >> 6223290

Recurrent glomerulonephritis.

G A Coles.   

Abstract

A patient with seven attacks of acute glomerulonephritis is described. Following each attack renal function returned to normal. Investigations strongly suggested immune complex disease as the cause of the nephritis but extensive tests failed to define the antigen. The possibility of an exogenous self-administered antigen is considered.

Entities:  

Mesh:

Year:  1983        PMID: 6223290      PMCID: PMC2417366          DOI: 10.1136/pgmj.59.687.60

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  A study of the association of group A streptococci with acute glomerulonephritis.

Authors:  S H BERNSTEIN; M STILLERMAN
Journal:  Ann Intern Med       Date:  1960-05       Impact factor: 25.391

2.  "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis.

Authors:  B R Cole; J T Brocklebank; R A Kienstra; J M Kissane; A M Robson
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

3.  Reversible crescentic glomerulonephritis following an acute exacerbation of chronic relapsing pancreatitis.

Authors:  J P Dickmeyer; W Wolfson; A Kowell; L Dornfeld
Journal:  Arch Intern Med       Date:  1977-08

4.  Recurrent acute renal failure due to antibiotic-induced interstitial nephritis.

Authors:  D Saltissi; C D Pusey; D J Rainford
Journal:  Br Med J       Date:  1979-05-05

5.  Self-induced glomerulonephritis.

Authors:  J M Boulton-Jones; J G Sissons; P F Naish; D J Evans; D K Peters
Journal:  Br Med J       Date:  1974-08-10

6.  Second attacks of acute glomerulonephritis.

Authors:  S Roy; H P Wall; J N Etteldorf
Journal:  J Pediatr       Date:  1969-11       Impact factor: 4.406

7.  Chronic membranoproliferative glomerulonephritis. A patient with recurrent episodes simulating rheumatic fever and acute nephritis.

Authors:  N Mendoza; N Mandalenakis; A Kanter; C L Pirani; V E Pollak
Journal:  Am J Med       Date:  1975-08       Impact factor: 4.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.